21 reports of this reaction
1.4% of all SILICON DIOXIDE reports
#18 most reported adverse reaction
HERPES ZOSTER is the #18 most commonly reported adverse reaction for SILICON DIOXIDE, manufactured by DNA Labs, Inc.. There are 21 FDA adverse event reports linking SILICON DIOXIDE to HERPES ZOSTER. This represents approximately 1.4% of all 1,547 adverse event reports for this drug.
Patients taking SILICON DIOXIDE who experience herpes zoster should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HERPES ZOSTER is a less commonly reported adverse event for SILICON DIOXIDE, but still significant enough to appear in the safety profile.
In addition to herpes zoster, the following adverse reactions have been reported for SILICON DIOXIDE:
The following drugs have also been linked to herpes zoster in FDA adverse event reports:
HERPES ZOSTER has been reported as an adverse event in 21 FDA reports for SILICON DIOXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HERPES ZOSTER accounts for approximately 1.4% of all adverse event reports for SILICON DIOXIDE, making it a notable side effect.
If you experience herpes zoster while taking SILICON DIOXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.